Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights
Disease area: Interstitial lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Vos, B. Vanaudenaerde, S. Verleden, S. De Vleeschauwer, A. Willems-Widyastuti, A. Schoonis, D. Van Raemdonck, L. Dupont, G. Verleden (Leuven, Belgium). A prospective, open-label pilot-study of azithromycin for lung allograft lymphocytic bronchiolitis: Preliminary results. Eur Respir J 2010; 36: Suppl. 54, 1680

Member's Comments

No comment yet.

Related content which might interest you: Preliminary results of pulmonary rehabilitation in interstitial lung diseases: A randomised controlled trial B32220095560 Source: Annual Congress 2011 - Exercise training: new populations, new techniques Year: 2011 Efficacy of fenspiride in infants with bronchiolitis: a preliminary open label clinical trial Source: Eur Respir J 2004; 24: Suppl. 48, 24s Year: 2004 Preliminary results of a prospective, multicentric randomized study comparing Interferon Gamma-1b (IFN-γ) and colchicine in the treatment of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2003 - Interstitial lung diseases Year: 2003 Comparison of Interferon gamma-1b (IFN-γ)and colcicine in the treatment of Idiopathic pulmonary fibrosis: preliminary results of a prospective, multicenter randomised study Source: Eur Respir J 2002; 20: Suppl. 38, 599s Year: 2002 Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019 Year: 2020 A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis Source: Eur Respir J , 49 (3) 1602486; DOI: 10.1183/13993003.02486-2016 Year: 2017 Azithromycin for sarcoidosis cough: an open-label exploratory clinical trial Source: ERJ Open Res, 6 (4) 00534-2020; 10.1183/23120541.00534-2020 Year: 2020 Helium-oxygen gas mixtures in infants with acute bronchiolitis: results of a phase III double-blind, multicentre RCT Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood Year: 2009 RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs Year: 2021 BAL neutrophil levels in a randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome post lung transplantation Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation Source: ERJ Open Res, 5 (4) 00167-2019; 10.1183/23120541.00167-2019 Year: 2019 Long term azithromycin treatment: A randomised placebo-controlled trial in non-CF bronchiectasis; results from the BAT trial Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011 Azithromycin for the treatment of cough in idiopathic pulmonary fibrosis: A randomized controlled cross-over pilot trial. Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020 Double-blind placebo controlled randomized trial of montelukast in acute RSV bronchiolitis Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 Multicenter, randomized, double-blind, placebo-controlled study (ORBIT 1) to evaluate the efficacy, safety, and tolerability of once daily ciprofloxacin for inhalation in the management of pseudomonas aeruginosa infections in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011 Randomized double-blind placebo-controlled trial of azithromycin in lung transplantation: first results Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation Year: 2008 Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study Source: ERJ Open Res, 4 (4) 00084-2018; 10.1183/23120541.00084-2018 Year: 2018 Efficacy of moxifloxacin for treatment of bronchial colonisation in COPD patients: a randomised, double-blind, placebo-controlled study Source: Annual Congress 2007 - Treatment and care of COPD Year: 2007 A randomized, placebo-controlled 3 years study of prophylactic azithromycin in 575 patients with chronic obstructive pulmonary disease(COPD) Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections Year: 2010